Edwards Lifesciences Corporation Free Cash Flow 2008–2025
Edwards Lifesciences Corporation reported $1.33B of free cash flow for fiscal 2025. That was 360.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +106.2%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $1.33B | +360.5% |
| FY 2024 | $289.90M | -54.9% |
| FY 2023 | $642.80M | -34.0% |
| FY 2022 | $973.60M | -30.8% |
| FY 2021 | $1.41B | +117.3% |
| FY 2020 | $647.30M | -30.3% |
| FY 2019 | $928.50M | +35.0% |
| FY 2018 | $688.00M | -17.4% |
| FY 2017 | $832.60M | +57.6% |
| FY 2016 | $528.30M | +18.2% |
| FY 2015 | $447.00M | -52.4% |
| FY 2014 | $939.40M | +158.3% |
| FY 2013 | $363.70M | +43.7% |
| FY 2012 | $253.10M | +9.3% |
| FY 2011 | $231.60M | +22.2% |
| FY 2010 | $189.60M | +87.2% |
| FY 2009 | $101.30M | -1.3% |
| FY 2008 | $102.60M | — |
Source: Edwards Lifesciences Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open EW 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Edwards Lifesciences Corporation reported $1.33B of free cash flow for fiscal 2025. That was 360.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +106.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Edwards Lifesciences Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEdwards Lifesciences Corporation — frequently asked questions
What is Edwards Lifesciences Corporation's free cash flow?
Edwards Lifesciences Corporation (EW) reported free cash flow of $1.33B for fiscal year 2025, per its SEC filings.
How has Edwards Lifesciences Corporation's free cash flow changed over time?
Between fiscal 2008 and 2025, EW's free cash flow grew at roughly 16.3% per year (compound annual rate), from $102.60M to $1.33B.
Where does this data come from?
Figures are computed from Edwards Lifesciences Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.